✦ LIBER ✦

US FDA to waive non-serious adverse event reporting

Book ID: 120876795
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 167 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199711050-00046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel Adverse Events of Bevacizumab in t

Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database

✍ Behrooz K. Shamloo, Pankdeep Chhabra, Andrew N. Freedman, Arnold Potosky, Jennif 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 159 KB

Prospective Data Mining of Six Products

Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System

✍ Dr Steven Bailey, Ajay Singh, Robert Azadian, Peter Huber, Michael Blum 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 174 KB

An Experimental Investigation of Masking

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

✍ Hsin-wei Wang, Alan M. Hochberg, Ronald K. Pearson, Dr Manfred Hauben 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 203 KB

Examination of pharmacists’ intention to

Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior

✍ Paul Gavaza; Carolyn M. Brown; Kenneth A. Lawson; Karen L. Rascati; James P. Wil 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Rise in serious ADRs reported to US FDA

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Increased Reporting to the FDA Adverse E

Increased Reporting to the FDA Adverse Event Reporting System (AERS) After Metoclopramide Black Box Warning

✍ Sifuentes, Humberto ;Parakkal, Deepak ;Somarriba, Gabriela C. ;Leikin, Jerrold B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 135 KB